Medication Augmentation after the Failure of SSRIs for Depression

Cited by (108)

Items 101–108 of 108

1. Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence
   2020 · Advances in Pharmacology
2. Keeping our eyes on STAR*D
   Valenstein, Marcia · 2006 · American Journal of Psychiatry
3. Depression Outcomes of Spanish- and English-Speaking Hispanic Outpatients in STAR*D
   Lesser, Ira, Zisook, Sidney, Flores, Deborah, Sciolla, Andres, Wisniewski, Stephen, Cook, Ian, Epstein, Marcy, Rosales, Aurora, Gonzalez, Carlos, Trivedi, Madhukar et al. · 2008 · Psychiatric Services
4. A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy
   Richards, Cynthia, Iosifescu, Dan V, Mago, Rajnish, Sarkis, Elias, Reynolds, James, Geibel, Brooke, Dauphin, Matthew · 2017 · Journal of Psychopharmacology
5. Identification and treatment of depression in minority populations
   Dejesus, Stania A., Diaz, Vanessa A., Gonsalves, Wanda C., Carek, Peter J. · 2011 · The International Journal of Psychiatry in Medicine
6. Treatment of mental health in patients with chronic liver disease
   Cotter, Thomas G., Beresford, Thomas · 2022 · Clinical Liver Disease
7. Antidepressant augmentation: Good news, limitations, and stumbling blocks
   Kocsis, James H. · 2015 · The Journal of Clinical Psychiatry
8. The portable transcranial electrical stimulation and internet-based behavioral therapy for major depression study (PSYLECT): results of the maintenance phase
   Aparicio, Luana V.M., Luethi, Matthias S., Borrione, Lucas, Moran, Natasha K.S., Cavendish, Beatriz A., Silva, Valquiria A., Valiengo, Leandro, Goerigk, Stephan, Padberg, Frank, Razza, Lais B. et al. · 2026 · Journal of Affective Disorders